Featured Posts

  

Recent Posts

  

Archive

  

Bloggers

  

Blog Roll

  

Dispatches From the Crossroads

Rss

United We Stand

Posted by: BIO Ventures for Global Health on 2/1/2012 | 0 Comments
New CEO Don Joseph has just returned from London, where the Gates Foundation, in conjunction with the World Health Organization and 13 of the world’s largest pharmaceutical companies, announced a new effort to end or control ten neglected tropical diseases. As we work together to achieve this goal, he writes, it is important to acknowledge that poverty and the neglect of populations create the environment that allows these diseases to thrive.

Testing, Testing

Posted by: BIO Ventures for Global Health on 1/6/2012 | 0 Comments
Diagnostics play a key role in our understanding and management of diseases   -- they can be used to evaluate and map disease prevalence, guide patient care, evaluate treatment efficacy, and measure the impact of control and prevention interventions. In order to better understand diagnostic needs and diagnostics currently in development for neglected diseases, we have expanded the Global Health Primer to include diagnostic development pipelines.

Developing Successes

Posted by: BIO Ventures for Global Health on 12/9/2011 | 0 Comments
Inequality. Patients’ needs. Progress (and lack of). Imbalance. Patents and the IP system. Sustainability. Access. Innovation. These are just some of the themes I heard addressed late last week at DNDi's annual partners’ meeting. These are not new themes in global health, yet they stimulated quite an array of passion and discussion at the DNDi sessions. I came away impressed by not only the passion but the commitment of the participants in addressing the issues.
Categories: Meetings

Industry Loosens its Purse Strings

Posted by: BIO Ventures for Global Health on 12/7/2011 | 0 Comments
According to today's launch of the 2011 G-FINDER survey, total investment in neglected disease R&D decreased in 2010. But private biopharmaceutical industry investment in neglected disease R&D made up a greater percentage of total neglected disease R&D investments than the Gates Foundation for the first time in the history of the survey. What does this mean for neglected disease R&D?
Categories: News

50 Years of Aid, Partnerships, & Innovations

Posted by: BIO Ventures for Global Health on 11/23/2011 | 0 Comments
Smallpox eradication in Africa. Polio eradication in Latin America. Vaccine biomonitors. Oral rehydration solutions. These major health advances would not have been possible without not only the funding — but the coordinating efforts — from the U.S. Agency for International Development (USAID). And as the agency celebrates its 50th year, its administrator, Dr. Rajiv Shah, continues to emphasize USAID’s renewed focus on technological innovations to drive sustainable solutions for a healthier, more prosperous world.

Step One

Posted by: BIO Ventures for Global Health on 10/31/2011 | 0 Comments
“A journey of a thousand miles begins with a single step.” Tom Mboya Okeyo, ambassador from Kenya, recalled the old Chinese proverb in referring to the expensive, risk-filled, and time-consuming process of drug and vaccine development for neglected tropical diseases at last week’s Geneva launch for WIPO Re:Search.
Categories: News Partnering

Diagnostics, Diseases, and Dilemmas

Posted by: BIO Ventures for Global Health on 9/26/2011 | 0 Comments
While non-communicable diseases account for the lion’s share of deaths worldwide, infectious diseases kill millions of people in the developing world, mostly children. Development of new diagnostics for such diseases accounts for less than 4% of total R&D spent. Clearly, there is a mismatch between the need for innovative diagnostics and the investments currently being made.

FDA Shines its Spotlight on Neglected Diseases

Posted by: BIO Ventures for Global Health on 9/1/2011 | 1 Comment
Last week, sponsors of neglected tropical disease drug applications got a glimpse into the minds of the U.S. Food and Drug Administration, which released guidance about how it plans to handle new drug applications for diseases such as malaria, dengue, cholera, and 11 other parasitic and bacterial infectious diseases that disproportionately affect developing nations.
Categories: News

Novartis Plays its PRV Card

Posted by: BIO Ventures for Global Health on 7/8/2011 | 0 Comments
Novartis, holder of the only PRV issued so far, recently announced that it used the voucher to obtain priority review of a supplemental biologic application (sBLA) for Ilaris (canakinumab), a humanized antibody. Some have argued that this spells the beginning of the end of the PRV program. Our view at BIO Ventures for Global Health is that rumors of the PRV’s demise are greatly exaggerated.
Categories: Incentives News

A Bucket Full of Worms

Posted by: BIO Ventures for Global Health on 6/24/2011 | 0 Comments
If I had a bucket full of earthworms, you might think I was looking forward to a big day of fishing. But what if I told you that my bucket full of worms came from a person rather than my backyard? My bucket full of worms isn’t from just any person – it’s from a single child who never even knew he was infected.
Categories: News
1 2 3 4 5 6 7 8  Go to Page:

  

Recent Comments

by Christian on Crossing the Valley of Death
"If the NIH could find a way to get the CAN funded then we could get some more research and development on the way. Congress just needs to approve the funding for this project. Thanks..." Read more »

by Christian Kaisan on Crossing the Valley of Death
"Thank you for your interesting blog article. The congress should approve the urgently needed aid money very soon." Read more »

by Gordon on Guiding the Voucher
"Glad to see an effort is made to improve the standards global healthcare. There is a general negative perception of drug and pharmaceutical companies because of the money hungry image they sometimes show. I hope that by working with BVGH, they can right that image, and prove that they too want to benefit the less fortunate and make healthcare more affordable to developing countries. " Read more »

  

Tag Cloud